Fighting the fakes: tackling substandard and falsified medicines

A recent comment written by Oksana Zirka Pyzik (UCL Fight the Fakes academic chapter founder and lead) published by nature reviews highlights how poor-quality or fraudulent medicines are causing extensive humanitarian and economic harm, particularly in Africa. Authors claim these products are a global problem that requires a coordinated cross-border response, including enhanced Read more…

The quality of veterinary medicines and their implications for One Health

A new study conducted by Vayouly Vidhamaly, Konnie Bellingham, Paul N Newton and Céline Caillet and published in the BMJ Journals shows that substandard and falsified veterinary medicines affect animal health, agricultural production and food security and will influence antimicrobial resistance (AMR) in both animals and humans.  According to the authors, Read more…

Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director, featured in the Medicine Maker

Image by the Medicine Maker Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director and Fight the Fakes board member, was recently featured in the Medicine Maker online magazine. In his article “Drug Supply Chain Security Act” Shabbir discussed how the US drug supply chain is not immune to falsified medicines Read more…

Securing trust in the global supply chain of COVID-19 vaccines

Deloitte‘s report calls for international healthcare organizations to promote global standards such as, Fight the Fakes member, GS1 DataMatrix barcode for product identification across the medical supply chain in order to ensure citizens around the world have a speedy, equal, and secure access to COVID-19 vaccines. The report, which follows another publication from Deloitte Read more…

Dangerous fakes – trade in counterfeit goods that pose health, safety and environmental risks​

Dangerous fakes – trade in counterfeit goods that pose health, safety and environmental risks A new study, conducted by the EU’s intellectual property office (EUIPO) and the Organisation for Economic Co-operation and Development (OECD), shines the spotlight on the scourge of falsified medicines, which have consequences on people’s health, confidence Read more…

Quality of medicines for life-threatening pregnancy complications in low- and middle-income countries: A systematic review

The research ‘Quality of medicines for life-threatening pregnancy complications in low- and middle-income countries: A systematic review’ published in 2020 by Maria Regina Torloni, Mercedes Bonet, Ana Pilar Betrán, Carolina C. Ribeiro-do-Valle, Mariana Widmer addresses concerns about the quality of medicines available in low- and middle-income countries (LMIC) to manage hemorrhage, pre-eclampsia/eclampsia Read more…

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

The recently published ‘The quality of medical products for cardiovascular diseases: a gap in global cardiac care’ paper, shows that one fifth of medicines reported as sampled in the literature were substandard or falsified. The research was carried out by experts from the MORU Tropical Health Network together with IDDO scientists. Given the Read more…